{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:05:44Z","timestamp":1783699544426,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Korea Medical Device Development","award":["RS-2023-00224382"],"award-info":[{"award-number":["RS-2023-00224382"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-11447-x","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:14:53Z","timestamp":1739902493000},"page":"5099-5109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Leptomeningeal metastases at recurrence in IDH-wildtype glioblastomas: incidence, risk factors, and prognosis based on postcontrast FLAIR imaging"],"prefix":"10.1007","volume":"35","author":[{"given":"Yae Won","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geon","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Been","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyunghwa","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na-Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0503-5558","authenticated-orcid":false,"given":"Sung Soo","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hee","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Koo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"11447_CR1","doi-asserted-by":"publisher","unstructured":"Akmal S, Ginalis EE, Patel NV, Aiken R, Dicpinigaitis AJ, Hanft SJ (2021) Leptomeningeal disease in glioblastoma: endgame or opportunity? J Neurooncol. https:\/\/doi.org\/10.1007\/s11060-021-03864-x","DOI":"10.1007\/s11060-021-03864-x"},{"key":"11447_CR2","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s11060-014-1592-1","volume":"120","author":"JJ Mandel","year":"2014","unstructured":"Mandel JJ, Yust-Katz S, Cachia D et al (2014) Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution. J Neurooncol 120:597\u2013605","journal-title":"J Neurooncol"},{"key":"11447_CR3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fneur.2014.00220","volume":"5","author":"C Dardis","year":"2014","unstructured":"Dardis C, Milton K, Ashby L, Shapiro W (2014) Leptomeningeal metastases in high-grade adult glioma: development, diagnosis, management, and outcomes in a series of 34 patients. Front Neurol 5:220","journal-title":"Front Neurol"},{"key":"11447_CR4","doi-asserted-by":"publisher","first-page":"e2483","DOI":"10.1212\/WNL.0000000000007529","volume":"92","author":"BM Andersen","year":"2019","unstructured":"Andersen BM, Miranda C, Hatzoglou V, DeAngelis LM, Miller AM (2019) Leptomeningeal metastases in glioma: the Memorial Sloan Kettering Cancer Center experience. Neurology 92:e2483\u2013e2491","journal-title":"Neurology"},{"key":"11447_CR5","doi-asserted-by":"publisher","first-page":"e1763","DOI":"10.1634\/theoncologist.2020-0258","volume":"25","author":"C Birzu","year":"2020","unstructured":"Birzu C, Tran S, Bielle F et al (2020) Leptomeningeal spread in glioblastoma: diagnostic and therapeutic challenges. Oncologist 25:e1763\u2013e1776","journal-title":"Oncologist"},{"key":"11447_CR6","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3174\/ajnr.A1937","volume":"31","author":"H Fukuoka","year":"2010","unstructured":"Fukuoka H, Hirai T, Okuda T et al (2010) Comparison of the added value of contrast-enhanced 3D fluid-attenuated inversion recovery and magnetization-prepared rapid acquisition of gradient echo sequences in relation to conventional postcontrast T1-weighted images for the evaluation of leptomeningeal diseases at 3T. AJNR Am J Neuroradiol 31:868\u2013873","journal-title":"AJNR Am J Neuroradiol"},{"key":"11447_CR7","doi-asserted-by":"publisher","unstructured":"Ahn SJ, Taoka T, Moon WJ, Naganawa S (2022) Contrast-enhanced fluid-attenuated inversion recovery in neuroimaging: a narrative review on clinical applications and technical advances. J Magn Reson Imaging. https:\/\/doi.org\/10.1002\/jmri.28117","DOI":"10.1002\/jmri.28117"},{"key":"11447_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/srep17758","volume":"5","author":"R Roelz","year":"2015","unstructured":"Roelz R, Reinacher P, Jabbarli R et al (2015) Surgical ventricular entry is a key risk factor for leptomeningeal metastasis of high grade gliomas. Sci Rep 5:17758","journal-title":"Sci Rep"},{"key":"11447_CR9","doi-asserted-by":"publisher","unstructured":"Yang J, Kwon JW, Shin SH et al (2022) Leptomeningeal metastasis in gliomas: clinical characteristics and risk factors. J Korean Neurosurg Soc. https:\/\/doi.org\/10.3340\/jkns.2022.0166","DOI":"10.3340\/jkns.2022.0166"},{"key":"11447_CR10","doi-asserted-by":"publisher","first-page":"E924","DOI":"10.1093\/neuros\/nyz144","volume":"85","author":"AM Mistry","year":"2019","unstructured":"Mistry AM, Kelly PD, Gallant JN et al (2019) Comparative analysis of subventricular zone glioblastoma contact and ventricular entry during resection in predicting dissemination, hydrocephalus, and survival. Neurosurgery 85:E924\u2013E932","journal-title":"Neurosurgery"},{"key":"11447_CR11","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/neuonc\/noac023","volume":"24","author":"SR Lowe","year":"2022","unstructured":"Lowe SR, Wang CP, Brisco A et al (2022) Surgical and anatomic factors predict development of leptomeningeal disease in patients with melanoma brain metastases. Neuro Oncol 24:1307\u20131317","journal-title":"Neuro Oncol"},{"key":"11447_CR12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s11060-022-04166-6","volume":"160","author":"F Battista","year":"2022","unstructured":"Battista F, Muscas G, Dinoi F, Gadda D, Della Puppa A (2022) Ventricular entry during surgical resection is associated with intracranial leptomeningeal dissemination in glioblastoma patients. J Neurooncol 160:473\u2013480","journal-title":"J Neurooncol"},{"key":"11447_CR13","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/neuros\/nyy202","volume":"83","author":"AM Mistry","year":"2018","unstructured":"Mistry AM, Kelly PD, Thompson RC, Chambless LB (2018) Cancer dissemination, hydrocephalus, and survival after cerebral ventricular entry during high-grade glioma surgery: a meta-analysis. Neurosurgery 83:1119\u20131127","journal-title":"Neurosurgery"},{"key":"11447_CR14","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3171\/2020.7.JNS201362","volume":"135","author":"JS Young","year":"2021","unstructured":"Young JS, Gogos AJ, Pereira MP et al (2021) Effects of ventricular entry on patient outcome during glioblastoma resection. J Neurosurg 135:989\u2013997","journal-title":"J Neurosurg"},{"key":"11447_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00401-018-1808-0","volume":"135","author":"DN Louis","year":"2018","unstructured":"Louis DN, Wesseling P, Paulus W et al (2018) cIMPACT-NOW update 1: not otherwise specified (NOS) and not elsewhere classified (NEC). Acta Neuropathol 135:481\u2013484","journal-title":"Acta Neuropathol"},{"key":"11447_CR16","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231\u20131251","journal-title":"Neuro Oncol"},{"key":"11447_CR17","doi-asserted-by":"crossref","unstructured":"Lee M, Karschnia P, Park YW et al (2024) Comparative analysis of molecular and histological glioblastomas: insights into prognostic variance. J Neurooncol 169:531\u2013541","DOI":"10.1007\/s11060-024-04737-9"},{"key":"11447_CR18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.neurad.2014.02.006","volume":"42","author":"M Nicolasjilwan","year":"2015","unstructured":"Nicolasjilwan M, Hu Y, Yan C et al (2015) Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients. J Neuroradiol 42:212\u2013221","journal-title":"J Neuroradiol"},{"key":"11447_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3174\/ajnr.A5421","volume":"39","author":"YW Park","year":"2018","unstructured":"Park YW, Han K, Ahn SS et al (2018) Prediction of IDH1-mutation and 1p\/19q-codeletion status using preoperative MR imaging phenotypes in lower grade gliomas. AJNR Am J Neuroradiol 39:37\u201342","journal-title":"AJNR Am J Neuroradiol"},{"key":"11447_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s40478-024-01832-w","volume":"12","author":"I Shin","year":"2024","unstructured":"Shin I, Park YW, Sim Y et al (2024) Revisiting gliomatosis cerebri in adult-type diffuse gliomas: a comprehensive imaging, genomic and clinical analysis. Acta Neuropathol Commun 12:128","journal-title":"Acta Neuropathol Commun"},{"key":"11447_CR21","doi-asserted-by":"publisher","first-page":"4804","DOI":"10.1002\/hbm.25159","volume":"41","author":"M Rebsamen","year":"2020","unstructured":"Rebsamen M, Rummel C, Reyes M, Wiest R, McKinley R (2020) Direct cortical thickness estimation using deep learning-based anatomy segmentation and cortex parcellation. Hum Brain Mapp 41:4804\u20134814","journal-title":"Hum Brain Mapp"},{"key":"11447_CR22","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S1470-2045(19)30098-1","volume":"20","author":"P Kickingereder","year":"2019","unstructured":"Kickingereder P, Isensee F, Tursunova I et al (2019) Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study. Lancet Oncol 20:728\u2013740","journal-title":"Lancet Oncol"},{"key":"11447_CR23","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1007\/s00330-022-08575-z","volume":"32","author":"YW Park","year":"2022","unstructured":"Park YW, Eom J, Kim D et al (2022) A fully automatic multiparametric radiomics model for differentiation of adult pilocytic astrocytomas from high-grade gliomas. Eur Radiol 32:4500\u20134509","journal-title":"Eur Radiol"},{"key":"11447_CR24","doi-asserted-by":"crossref","unstructured":"Park YW, Choi KS, Foltyn-Dumitru M et al (2024) Incorporating supramaximal resection into survival stratification of IDH-wildtype glioblastoma: a refined multi-institutional recursive partitioning analysis. Clin Cancer Res 30:4866\u20134875","DOI":"10.1158\/1078-0432.CCR-23-3845"},{"key":"11447_CR25","doi-asserted-by":"publisher","unstructured":"Karschnia P, Young JS, Dono A et al (2022) Prognostic validation of a new classification system for extent of resection in glioblastoma: a report of the RANO resect group. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noac193","DOI":"10.1093\/neuonc\/noac193"},{"key":"11447_CR26","doi-asserted-by":"publisher","unstructured":"Karschnia P, Dietrich J, Bruno F et al (2023) Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noad160","DOI":"10.1093\/neuonc\/noad160"},{"key":"11447_CR27","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1093\/neuonc\/noad133","volume":"25","author":"JS Young","year":"2023","unstructured":"Young JS, Morshed RA, Hervey-Jumper SL, Berger MS (2023) The surgical management of diffuse gliomas: current state of neurosurgical management and future directions. Neuro Oncol 25:2117\u20132133","journal-title":"Neuro Oncol"},{"key":"11447_CR28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/neuonc\/now197","volume":"19","author":"M Chamberlain","year":"2017","unstructured":"Chamberlain M, Junck L, Brandsma D et al (2017) Leptomeningeal metastases: a RANO proposal for response criteria. Neuro Oncol 19:484\u2013492","journal-title":"Neuro Oncol"},{"key":"11447_CR29","doi-asserted-by":"publisher","first-page":"iv84","DOI":"10.1093\/annonc\/mdx221","volume":"28","author":"E Le Rhun","year":"2017","unstructured":"Le Rhun E, Weller M, Brandsma D et al (2017) EANO-ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours. Ann Oncol 28:iv84\u2013iv99","journal-title":"Ann Oncol"},{"key":"11447_CR30","doi-asserted-by":"crossref","unstructured":"Le Rhun E, Weller M, van den Bent M et al (2023) Leptomeningeal metastasis from solid tumours: EANO\u2013ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. ESMO Open 8:101624","DOI":"10.1016\/j.esmoop.2023.101624"},{"key":"11447_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3171\/2022.9.JNS221659","volume":"139","author":"YW Park","year":"2023","unstructured":"Park YW, Han K, Park JE et al (2023) Leptomeningeal metastases in glioma revisited: incidence and molecular predictors based on postcontrast fluid-attenuated inversion recovery imaging. J Neurosurg 139:38\u201348","journal-title":"J Neurosurg"},{"key":"11447_CR32","doi-asserted-by":"publisher","unstructured":"Park YW, Jang G, Kim SB et al (2024) Leptomeningeal metastases in IDH-wildtype glioblastomas revisited: comprehensive analysis of incidence, risk factors, and prognosis based on post-contrast FLAIR. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noae091","DOI":"10.1093\/neuonc\/noae091"},{"key":"11447_CR33","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s10549-011-1682-0","volume":"129","author":"S Lee","year":"2011","unstructured":"Lee S, Ahn HK, Park YH et al (2011) Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations. Breast Cancer Res Treat 129:809\u2013817","journal-title":"Breast Cancer Res Treat"},{"key":"11447_CR34","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/1759-7714.13296","volume":"11","author":"BS Kwon","year":"2020","unstructured":"Kwon BS, Cho YH, Yoon SK et al (2020) Impact of clinicopathologic features on leptomeningeal metastasis from lung adenocarcinoma and treatment efficacy with epidermal growth factor receptor tyrosine kinase inhibitor. Thorac Cancer 11:436\u2013442","journal-title":"Thorac Cancer"},{"key":"11447_CR35","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/path.1711030407","volume":"103","author":"OE Eade","year":"1971","unstructured":"Eade OE, Urich H (1971) Metastasising gliomas in young subjects. J Pathol 103:245\u2013256","journal-title":"J Pathol"},{"key":"11447_CR36","doi-asserted-by":"publisher","first-page":"834","DOI":"10.3171\/jns.1994.80.5.0834","volume":"80","author":"JP Elliott","year":"1994","unstructured":"Elliott JP, Keles GE, Waite M, Temkin N, Berger MS (1994) Ventricular entry during resection of malignant gliomas: effect on intracranial cerebrospinal fluid tumor dissemination. J Neurosurg 80:834\u2013839","journal-title":"J Neurosurg"},{"key":"11447_CR37","doi-asserted-by":"publisher","unstructured":"Vollmuth P, Karschnia P, Sahm F, Park YW, Ahn SS, Jain R (2024) A radiologist\u2019s guide to IDH-wildtype glioblastoma for efficient communication with clinicians: part II\u2013essential information on post-treatment imaging. Korean J Radiol 26:e14. https:\/\/doi.org\/10.3348\/kjr.2024.0983","DOI":"10.3348\/kjr.2024.0983"},{"key":"11447_CR38","doi-asserted-by":"publisher","unstructured":"Park YW, Han K, Kim S et al (2023) Revisiting prognostic factors in glioma with leptomeningeal metastases: a comprehensive analysis of clinical and molecular factors and treatment modalities. J Neurooncol. https:\/\/doi.org\/10.1007\/s11060-022-04233-y","DOI":"10.1007\/s11060-022-04233-y"},{"key":"11447_CR39","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1212\/WNL.29.10.1369","volume":"29","author":"JP Glass","year":"1979","unstructured":"Glass JP, Melamed M, Chernik NL, Posner JB (1979) Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology 29:1369\u20131375","journal-title":"Neurology"},{"key":"11447_CR40","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11060-017-2452-6","volume":"133","author":"E Le Rhun","year":"2017","unstructured":"Le Rhun E, Rud\u00e0 R, Devos P et al (2017) Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe. J Neurooncol 133:419\u2013427","journal-title":"J Neurooncol"},{"key":"11447_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13234","volume":"34","author":"B Lee","year":"2024","unstructured":"Lee B, Hwang S, Bae H, Choi KH, Suh YL (2024) Diagnostic utility of genetic alterations in distinguishing IDH-wildtype glioblastoma from lower-grade gliomas: insight from next-generation sequencing analysis of 479 cases. Brain Pathol 34:e13234","journal-title":"Brain Pathol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11447-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11447-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11447-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T16:16:33Z","timestamp":1751559393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11447-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["11447"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11447-x","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"11 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Professor Seung-Koo Lee, MD, PhD, from Yonsei University College of Medicine (slee@yuhs.ac).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We consulted a PhD who has significant statistical expertise (K.H., a biostatistician with 16 years of experience in biostatistics).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"The institutional review board waived the requirement to obtain informed patient consent for this retrospective study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The Institutional Review Board of our university waived the requirement for informed patient consent for this retrospective study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"There is no overlapping in study subjects.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}